US Drug Recall Register
Class II · Moderate risk Completed Initiated Oct 5, 2022 (4 years ago)

Quinapril and Hydrochlorothiazide Tablets, USP 20mg/12.5mg, 90 Tablets bottles…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.

What was recalled

Quinapril and Hydrochlorothiazide Tablets, USP 20mg/12.5mg, 90 Tablets bottles Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520, Made in India, NDC 65862-162-90

Recalling firm
Aurobindo Pharma USA Inc.
NDC code
65862-162-90
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0021-2023

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other East recalls

See all